MedPath

ACT PREGABALIN

ACT PREGABALIN

Discontinued
DIN Number

02402963

Drug Class

Human

Market Date

N/A

Company
HC

actavis pharma company

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02402963
AIG Number0151121006
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N02BF02 PREGABALIN
Product Specifications
Dosage FormCapsule
Route of AdministrationOral
AHFS Classification28:12.92
Health Canada Classification

ACTIVE INGREDIENTS (1)

PREGABALINActive
Strength: 200 MG
Monograph: PREGABALIN

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.